Business Today: Stock futures rise after Cyprus deal, S&P record in sight

		Click to View in Browser 03/25/2013 Stock futures rise after Cyprus deal, S&P record in sight NEW YORK (Reuters) - Stock futures rose on Monday after negotiators reached a deal hours before a deadline to avert a financial meltdown in Cyprus and the country's possible exit from the euro zone. Cyprus reaches last-minute deal on 10 billion euro bailout BRUSSELS/NICOSIA (Reuters) - Cyprus clinched a last-ditch deal with international lenders to shut down its second-largest bank and inflict heavy losses on uninsured depositors, including wealthy Russians, in return for a 10 billion euro ($13 billion) bailout. BlackBerry shares slide on Goldman downgrade TORONTO (Reuters) - BlackBerry stock fell nearly 4 percent on Monday after Goldman Sachs cut its rating, citing a disappointing U.S. launch for the smartphone maker's new touchscreen device that went on sale in the United States on Friday. Regulators approve plan for lost money in Facebook IPO (Reuters) - Regulators approved on Monday a plan to compensate market makers who lost money in a botched Facebook Inc public offering on Nasdaq OMX Group Inc's Nasdaq exchange. Dell says Blackstone, Icahn offers may be superior (Reuters) - Dell Inc said it received alternative proposals from Blackstone Group LP and Carl Icahn that could be superior to the $24.4 billion offer from founder Michael Dell and private equity fund Silver Lake Partners last month. Insight: In Ohio, the fog begins to lift over the Utica shale NEW YORK (Reuters) - Shares of Gulfport Energy were in free fall last spring, dropping 55 percent in four months, until the oil and gas producer announced it had drilled its first three wells in the Utica shale formation in Ohio. TNT Express cuts 6 percent of jobs to face future alone AMSTERDAM (Reuters) - Dutch package delivery firm TNT Express said on Monday it will cut 4,000 jobs and focus on Europe after a failed $7 billion takeover by United Parcel Service . AstraZeneca settles Crestor patent row LONDON (Reuters) - AstraZeneca has seen off a remaining threat to its top-selling cholesterol drug Crestor by settling a U.S. legal case with generic firms Watson Laboratories, a unit of Actavis , and Egis . SEC's Walter urges "maximum" reliance on foreign swaps rules WASHINGTON (Reuters) - The top securities regulator is urging international market regulators to find a compromise as they struggle to agree on how to apply new rules for cross border over-the-counter derivatives trades. Stop-gap spending measure funds MEADS missile defense WASHINGTON (Reuters) - A stop-gap spending measure passed by the Congress last week will allow Lockheed Martin Corp and its partners in Italy and Germany to complete the last year of development of a missile defense system, averting possible termination fees and international fallout. Related Video Market Pulse: What's Moving Today and Why Cyprus highlights euro zone bailouts getting harder to agree Economic News IMF draft cuts 2013 U.S. growth forecast: report Fed's Raskin says economy too reliant on low-wage jobs A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend